Pat Soon-Shiong, Chairman of Chan Soon-Shiong Family Foundation, Executive Chairman at ImmunityBio, Executive Chairman of Los Angeles Times, shared a post on X:
“In order to provide us much access as possible we have opened randomized trials CSSIFM for the following cancers: non small cell lung cancer in which patients have failed chemo and checkpoint inhibitors / glioblastoma failed surgery, radiation and temodor. Soon advanced colon cancer, papillary bladder cancer failed BCG and HPV positive cancers.”
More posts featuring Pat Soon-Shiong.